Arkolith/Insider Trading/AUPH/Form 4

Miller Joseph M

Chief Financial OfficerAurinia Pharmaceuticals Inc. (AUPH) · full profile →Form 4 · filed Mar 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$940K
Net Open-Market Flow
-$940K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2025Sell(S)56K$7.92$445K577K
Mar 3, 2025Sell(S)62K$8.00$495K634K
Mar 3, 2025Grant(A)115K—$0695K
Feb 28, 2025Grant(A)81K—$0581K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2025Grant(A)124K—$0124K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001600620-25-000020) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML